Anixa Biosciences Inc (ANIX) Stock Analysis

Anixa Biosciences Inc (ANIX) is a publicly traded company in the HEALTHCARE sector. It trades at $2.55, carries a market capitalization of $90.53M. This page summarizes the public market data, fundamentals, and frequently asked questions for ANIX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.55
• Market Cap: $90.53M
• EPS: $-0.32
• 52-Week High: $5.46
• 52-Week Low: $2.44

Market Sentiment

Anixa Biosciences Inc currently has a Bullish sentiment score of 0.46.

About Anixa Biosciences Inc

Anixa Biosciences Inc. is a forefront biotechnology company located in San Jose, California, dedicated to addressing critical unmet medical needs in oncology and infectious diseases through the development of groundbreaking therapies and vaccines. The firm is characterized by a robust pipeline fueled by cutting-edge technologies aimed at improving patient outcomes in challenging health scenarios. By strategically focusing on high-impact sectors within the biopharmaceutical landscape, Anixa is...

GNG Research Analysis

GNG Research scores Anixa Biosciences Inc (ANIX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ANIX.

Frequently Asked Questions

Does ANIX pay dividends?

Anixa Biosciences Inc (ANIX) does not currently pay a regular dividend.

What is ANIX's market cap?

Anixa Biosciences Inc (ANIX) has a market capitalization of $90.53M with a current stock price of $2.55.